Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Alternative names
carcik-cd19 (3 trials)
Leukemia (Phase 2)
Leukemia, Lymphoid (Phase 2)
Precursor Cell Lymphoblastic Leukemia-Lymphoma (Phase 2)
Trials (3 total)
Trial APIs (1 total)